Advanced search
Publication Cover
Cancer Biology & Therapy Volume 15, 2014 - Issue 3
Submit an article Journal homepage
800
Views
8
CrossRef citations to date
0
Altmetric
Clinical Case Report

Increase in antibody-dependent cellular cytotoxicity (ADCC) in a patient with advanced colorectal carcinoma carrying a KRAS mutation under lenalidomide therapy

Gabriele Gamerith Clinic for Internal Medicine V; Innsbruck Medical University; Innsbruck, AustriaCorrespondence[email protected]
,
Thomas Auer Clinic for Radiology; Innsbruck Medical University; Innsbruck, Austria
,
Arno Amann Clinic for Internal Medicine V; Innsbruck Medical University; Innsbruck, Austria
,
Daniel Putzer Clinic for Radiology; Innsbruck Medical University; Innsbruck, Austria
,
Bettina Schenk Clinic for General and Surgical Intensive Care; Innsbruck Medical University; Innsbruck, Austria
,
Brigitte Kircher Clinic for Internal Medicine V; Innsbruck Medical University; Innsbruck, Austria
,
Wolfgang Hilbe Clinic for Internal Medicine V; Innsbruck Medical University; Innsbruck, Austria
,
Heinz Zwierzina Clinic for Internal Medicine V; Innsbruck Medical University; Innsbruck, Austria
&
Judith Loeffler-Ragg Clinic for Internal Medicine VI; Innsbruck Medical University; Innsbruck, Austria
 show all
Pages 266-270 | Received 27 Mar 2013, Accepted 23 Nov 2013, Published online: 18 Dec 2013

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dan Liang, Cong Wei, Xiaoting Zhang, Jilong Yang, Yaling Zheng, Jingwen Du, Liang Wang & Lan Deng. (2021) Efficacy of lenalidomide for relapsed or refractory T lymphoblastic lymphoma/leukemia after allogeneic hematopoietic stem cell transplantation. Leukemia & Lymphoma 62:10, pages 2521-2525.
Read now

Articles from other publishers (7)

Yuanshuo A. Wang, Daniel Ranti, Christine Bieber, Matthew Galsky, Nina Bhardwaj, John P. Sfakianos & Amir Horowitz. (2023) NK Cell-Targeted Immunotherapies in Bladder Cancer: Beyond Checkpoint Inhibitors. Bladder Cancer 9:2, pages 125-139.
Crossref
Hasan Baysal, Ines De Pauw, Hannah Zaryouh, Marc Peeters, Jan Baptist Vermorken, Filip Lardon, Jorrit De Waele & An Wouters. (2021) The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies. Frontiers in Immunology 12.
Crossref
Chao Ma, Xin Zhang, Xudong Zhao, Nan Zhang, Sixin Zhou, Yonghui Zhang & Peiyu Li. (2021) Predicting the Survival and Immune Landscape of Colorectal Cancer Patients Using an Immune-Related lncRNA Pair Model. Frontiers in Genetics 12.
Crossref
Yi-Hsin Liang, Jia-Huei Tsai, Yung-Ming Cheng, Kuang-Yu Chan, Wen-Ling Hsu, Chang-Cheng Lee, Kuo-Hsing Chen & Kun-Huei Yeh. (2021) Chemotherapy agents stimulate dendritic cells against human colon cancer cells through upregulation of the transporter associated with antigen processing. Scientific Reports 11:1.
Crossref
Alessandro Poggi, Serena Varesano & Maria Raffaella Zocchi. (2018) How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive. Frontiers in Immunology 9.
Crossref
Robert L. Ferris, Heinz-Josef Lenz, Anna Maria Trotta, Jesús García-Foncillas, Jeltje Schulten, François Audhuy, Marco Merlano & Gerard Milano. (2018) Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation. Cancer Treatment Reviews 63, pages 48-60.
Crossref
Jian Liu, Yuhu Cheng, Xuesong Wang, Lin Zhang & Hui Liu. (2017) An Optimal Mean Based Block Robust Feature Extraction Method to Identify Colorectal Cancer Genes with Integrated Data. Scientific Reports 7:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.